Gray Brian R.
Known title: President & CEOCIK: 0001966900
Gray Brian R.'s purchase track record
Gray Brian R. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/29/2024 | KNF | $74 | -4.7% | +4.8% | +9.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| KNF | ▲ Buy | Grant | 20,955 | $0 | 3/6/2026 | View on chart |
| KNF | ▼ Sell | Tax Withholding | 10,072 | $823K | 2/12/2026 | View on chart |
| KNF | ▼ Sell | Tax Withholding | 19,572 | $1.6M | 2/12/2026 | View on chart |
| KNF | ▲ Buy | Grant | 12,599 | $0 | 2/28/2025 | View on chart |
| KNF | ▲ Buy | Open Market | 1 | $74 | 2/29/2024 | View on chart |
| KNF | ▲ Buy | Grant | 17,769 | $0 | 2/22/2024 | View on chart |
| KNF | ▲ Buy | Grant | 41,696 | $0 | 7/12/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
RBC and Wells Fargo lower Knife River price targets
RBC downgraded Knife River to Sector Perform and cut its price target to $58, citing potential impacts from input costs on construction volumes. Wells Fargo also lowered its target to $54 while maintaining an Equal-Weight rating. These moves reflect growing caution among analysts regarding the company's near-term outlook, even as the stock trades below its 52-week high.
RBC and Wells Fargo lower Knife River price targets. RBC downgraded Knife River to Sector Perform and cut its price target to $58, citing potential impacts from input costs on construction volumes. Wells Fargo also lowered its target to $54 while maintaining an Equal-Weight rating. These moves reflect growing caution among analysts regarding the company's near-term outlook, even as the stock trades below its 52-week high.